Table 1.
Characteristics | N = 139 (%) |
---|---|
Male | 95 (68.3) |
Mean age | 63.9 (57.0–75.0) |
Previous endocarditis | 9 (6.5) |
Congenital heart disease | 14 (10.1) |
Previous valve surgery | 47 (33.8) |
Prosthetic valve at admission | 46 (33.1) |
Device therapy at admission | 17 (12.2) |
Positive culture | 127 (91.4) |
Positive culture, major criterium | 106 (76.3) |
Positive culture, minor criterium | 21 (15.1) |
Staphylococcus aureus | 31 (22.3) |
Streptococci | 59 (42.4) |
Enterococci | 16 (11.5) |
Other | 24 (17.3) |
Native valve endocarditis | 85 (61.2) |
Prosthetic valve endocarditis | 45 (32.4) |
Cardiac device related IE | 10 (7.2) |
Aortic root/ascending aorta prosthesis IE | 5 (3.6) |
Aortic valve IE | 87 (62.6) |
Mitral valve IE | 41 (29.5) |
Pulmonary valve IE | 6 (4.3) |
Tricuspid valve IE | 3 (2.2) |
Surgery | 70 (50.4) |
Possible IE | 23 (16.5) |
Definite IE | 116 (83.5) |
Values expressed as N (percentage) and median (interquartile range)